Sabrina Schrauf

发表

Changing the Protease Speciﬁcity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus (cid:1)

C. Mandl, Wolfgang Fischl, Sigrid Elshuber, 2008 .

Functional Analysis of Potential Carboxy-Terminal Cleavage Sites of Tick-Borne Encephalitis Virus Capsid Protein

C. Mandl, T. Skern, Petra Schlick, 2007, Journal of Virology.

Generation and genetic stability of tick-borne encephalitis virus mutants dependent on processing by the foot-and-mouth disease virus 3C protease.

C. Mandl, T. Skern, M. Kurz, 2012, Journal of General Virology.

Biodistribution and toxicology evaluation of a recombinant measles Schwarz‐based Lassa vaccine in cynomolgus macaques

W. P. Duprex, Roland Tschismarov, E. Tauber, 2022, Journal of applied toxicology : JAT.

Extension of Flavivirus Protein C Differentially Affects Early RNA Synthesis and Growth in Mammalian and Arthropod Host Cells

C. Mandl, L. Bell-Sakyi, T. Skern, 2009, Journal of Virology.

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Roland Tschismarov, E. Tauber, Katrin Ramsauer, 2020, Frontiers in Immunology.

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

E. Wang, S. Weaver, Sasha R. Azar, 2019, The Journal of infectious diseases.

Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus

C. Mandl, Wolfgang Fischl, Sigrid Elshuber, 2008, Journal of Virology.

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial

M. Mateo, S. Baize, P. Damme, 2023, The Lancet.

Generation and genetic stability of tick-borne encephalitis virus mutants dependent on processing by the foot-and-mouth disease virus 3C protease.

C. Mandl, T. Skern, M. Kurz, 2012, The Journal of general virology.